Suppression of inflammation response by a novel A3 adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling
Keywords: A3AR, A3 adenosine receptor; iNOS, inducible nitric oxide synthase; LPS, lipopolysaccharide; IL-1β, interleukin-1β; IL-6, interleukin-6; NF-κB, nuclear factor-κB; PI3 kinase, phosphatidylinositol 3-kinase; TNF-α, tumor necrosis factor-αA3AR agonist; Anti-